Page 1 of Clinical Trials for Relapsed tumors, 3643 Total Matches
- 1CompletedLast Updated: July 6, 2011Condition(s): Neoplasms
- 2CompletedLast Updated: February 23, 2012Condition(s): Non-Small-Cell Lung Cancer; Lung Cancer, Non-Small Cell
- 3Active, not recruitingLast Updated: March 14, 2012Condition(s): Ovarian Neoplasm
- 4RecruitingLast Updated: May 23, 2012Condition(s): Brain and Central Nervous System Tumors; Lymphoma; Neuroblastoma; Unspecified Childhood Solid Tumor, Protocol Specific
- 5RecruitingLast Updated: April 20, 2012Condition(s): Relapsed or Refractory Solid Tumors
- 6CompletedLast Updated: July 7, 2009Condition(s): Relapsed or Cisplatin-Refractory Germ Cell Cancer
- 7RecruitingLast Updated: November 18, 2011Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Carcinoma
- 8CompletedLast Updated: April 28, 2011Condition(s): Small Cell Lung Cancer
- 9RecruitingLast Updated: April 26, 2012Condition(s): Hematopoietic Stem Cell Transplantation; Solid Tumor; Transplantation, Autologous
- 10CompletedLast Updated: July 7, 2011Condition(s): Hematologic Malignancies; Leukemia; Myelodysplastic Syndromes; Myeloid Metaplasia; Lymphoma
- 11Active, not recruitingLast Updated: June 24, 2011Condition(s): Small Cell Lung Cancer
- 12RecruitingLast Updated: February 27, 2012Condition(s): Small Cell Lung Cancer
- 13CompletedLast Updated: August 3, 2011Condition(s): Relapsed or Refractory Hematological Malignancies
- 14TerminatedLast Updated: April 20, 2007Condition(s): Platinum Sensitive Relapsed Ovarian Cancer
- 15TerminatedLast Updated: April 28, 2011Condition(s): Small Cell Lung Cancer
- 16TerminatedLast Updated: July 21, 2011Condition(s): Breast Cancer
- 17Active, not recruitingLast Updated: January 24, 2012Condition(s): Solid Tumor Malignancies
- 18CompletedLast Updated: March 17, 2011Condition(s): Neoplasms, Breast; Breast Cancer
- 19Active, not recruitingLast Updated: June 10, 2011Condition(s): Advanced Solid Tumors; Multiple Myeloma
- 20CompletedLast Updated: January 16, 2012Condition(s): Relapsed or Refractory Lymphoproliferative Malignancies; Hodgkin's Lymphoma; Peripheral T-cell Lymphoma; B-cell Lymphoma; Waldenstrom's Macroglobulinemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Relapsed+tumors
